Clinical and Practical Psychopharmacology

Page 4

Clinical and Practical Psychopharmacology

Second-Generation Antipsychotics and Major Congenital Malformations

October 5, 2021

This article looks at recent large studies of the safety of SGAs in order to weigh the benefits and risks of treatment during pregnancy.

Chittaranjan Andrade

Clinical and Practical Psychopharmacology

Predictors of 6- and 12-Month Relapse After Stopping ECT

August 10, 2021

What contributes to relapse after electroconvulsive therapy? Dr Andrade discusses the findings of 2 recent studies on this question and critically examines their methodology.

Chittaranjan Andrade

Clinical and Practical Psychopharmacology

Anesthesia for ECT: A Niche Role for Sevoflurane

August 3, 2021

Dr Andrade takes a closer look at the use of sevoflurane for anesthesia during electroconvulsive therapy; although its routine use is not advisable, it may be a good solution…

Chittaranjan Andrade

Clinical and Practical Psychopharmacology

Fluoxetine for Stroke: A Mixed Bag of Outcomes

June 8, 2021

Dr Andrade discusses the findings of a meta-analysis and two recent RCTs that indicate fluoxetine may not be a good choice in patients recovering from stroke.

Chittaranjan Andrade

Clinical and Practical Psychopharmacology

β-Blockers and the Risk of New-Onset Depression

June 1, 2021

β-Blocker treatment has long been associated with depression, but is there more to the story than meets the eye? Dr Andrade considers the findings of a recent large meta-analysis—and…

Chittaranjan Andrade

Clinical and Practical Psychopharmacology

A Rebuttal of Criticisms of ECT

March 30, 2021

Electroconvulsive therapy has a negative connotation in many circles, but is it getting a bad rap? Dr Andrade offers thoughtful counterpoints to the criticism.

Chittaranjan Andrade

Clinical and Practical Psychopharmacology

Prazosin for Alcohol Use Disorder

March 23, 2021

Could prazosin help patients with alcohol use disorder who experience intense withdrawal symptoms? Dr Andrade considers the evidence and the findings of a recent large RCT.

Chittaranjan Andrade

Clinical and Practical Psychopharmacology

N-Acetylcysteine Augmentation for Patients With Major Depressive Disorder and Bipolar Depression

February 18, 2021

Two recent meta-analyses found little effect of N-acetylcysteine augmentation in MDD or bipolar depression, although some past research has indicated its efficacy. In this article, Dr Andrade takes a…

Chittaranjan Andrade

Clinical and Practical Psychopharmacology

HARKing, Cherry-Picking, P-Hacking, and Data Dredging as Questionable Research Practices

February 18, 2021

In this article, Dr Andrade helps readers identify several types of statistical analysis that violate scientific principles and that researchers may knowingly—or unknowingly—engage in.

Chittaranjan Andrade

Clinical and Practical Psychopharmacology

Paternal Depression as a Risk Factor for Neurodevelopmental Disorders in Offspring

December 1, 2020

Gestational exposure to antidepressants has been associated with risk of autism and ADHD, and a recent study also showed maternal depression as a risk factor. Intriguingly, paternal depression was…

Chittaranjan Andrade

Clinical and Practical Psychopharmacology

Gabapentin for Alcohol-Related Disorders

November 24, 2020

This article examines a role for gabapentin in reducing alcohol consumption in a specific subpopulation of alcohol use disorder patients: those with high alcohol intake and high levels of…

Chittaranjan Andrade

Clinical and Practical Psychopharmacology

Basics of Conducting Meta-Analysis

October 6, 2020

Read a full article on the basics of conducting meta-analysis. What it is, why it is necessary, and how to interpret a forest plot.

Chittaranjan Andrade

« 1 2 3 4 5 6 … 13 »